INJECTION SITE ATROPHY side effect
What is INJECTION SITE ATROPHY ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
INJECTION SITE ATROPHY and Recently Reported Side Effects
INJECTION SITE ATROPHY and 15 most Active Side Effect polls
INJECTION SITE ATROPHY and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with INJECTION SITE ATROPHY
BETASERON FUZEON KENALOG MEDROXYPROGESTER NORDITROPIN REBIF SANDOSTATIN VOLTARENKenalog Side Effects Report #5662547-X
Consumer or non-health professional from UNITED STATES reported KENALOG problem on Mar 10, 2008. Female patient, 28 years of age, weighting 130.0 lb, was diagnosed with hypersensitivity and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . KENALOG dosage: unknown. Patient recovered.
Kenalog Side Effects Report #5637227-7
KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2007. Female patient, 42 years of age, weighting 127.9 lb, was diagnosed with sinusitis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, menorrhagia, muscle spasms, . KENALOG dosage: unknown. During the same period patient was treated with SYNTHROID. Patient recovered.
Rebif Side Effects Report #5528133-7
Consumer or non-health professional from NORWAY reported REBIF problem on Nov 06, 2007. Female patient, 37 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . REBIF dosage: unknown. Patient recovered.
Kenalog Side Effects Report #5530728-1
KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Female patient, 51 years of age, weighting 130.1 lb, was diagnosed with rash and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site erythema, . KENALOG dosage: unknown. During the same period patient was treated with SECTRAL. Patient recovered.
Kenalog Side Effects Report #5530729-3
Consumer or non-health professional from UNITED STATES reported KENALOG problem on May 29, 2007. Female patient, 35 years of age, weighting 121.3 lb, was diagnosed with rash macular, allergic sinusitis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . KENALOG dosage: REC'D 40 MG IM ON 08-SEP-2005 AND 06-OCT-2005. During the same period patient was treated with SYNTHROID, YASMIN. Patient recovered.
Kenalog Side Effects Report #5532959-3
KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2007. Female patient, child 4 years of age, weighting 25.00 lb, was diagnosed with multiple allergies and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . KENALOG dosage: unknown. Patient recovered.
Kenalog Side Effects Report #5493295-7
Consumer or non-health professional from UNITED STATES reported KENALOG problem on Sept 14, 2006. Female patient, 33 years of age, weighting 132.3 lb, was diagnosed with haemorrhoids and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, menstruation irregular, . KENALOG dosage: unknown. During the same period patient was treated with VITAMINS. Patient recovered.
Kenalog Side Effects Report #5493309-4
KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient, 30 years of age, weighting 108.0 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . KENALOG dosage: unknown. Patient was hospitalized. Patient recovered.
Kenalog Side Effects Report #5493328-8
Consumer or non-health professional from UNITED STATES reported KENALOG problem on June 15, 2007. Female patient, weighting 114.6 lb, was diagnosed with multiple allergies and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, pain in extremity, . KENALOG dosage: unknown. Patient recovered.
Sandostatin Side Effects Report #5709696-5
SANDOSTATIN LAR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2008. Female patient, 52 years of age, was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . SANDOSTATIN LAR dosage: 20 MG, UNK. Patient recovered.
Kenalog Side Effects Report #5712712-8
Consumer or non-health professional from UNITED STATES reported KENALOG problem on Apr 21, 2008. Female patient, child 11 years of age, weighting 95.00 lb, was diagnosed with dermatitis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site reaction, pain of skin, scar, . KENALOG dosage: 40 MG 1 SHOT IM. Patient recovered.
Norditropin Side Effects Report #5717423-0
NORDITROPIN NORDIFLEX problem was reported by a Health Professional from UNITED STATES on Apr 24, 2008. Female patient, weighting 69.00 lb, was diagnosed with growth hormone deficiency and was treated with NORDITROPIN NORDIFLEX. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . NORDITROPIN NORDIFLEX dosage: 1.3MG DAILY SQ. During the same period patient was treated with PREVACID, CELEXA, MVI WITH IRON, HYOSCYAMIN. Patient recovered.
Voltaren Side Effects Report #5360200-3
Physician from FRANCE reported VOLTAREN problem on June 04, 2007. Female patient, 48 years of age, was diagnosed with back pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site discolouration, injection site fibrosis, injection site reaction, . VOLTAREN dosage: 75 MG, UNK. During the same period patient was treated with COLTRAMYL. Patient recovered.
Fuzeon Side Effects Report #5332318-2
FUZEON problem was reported by a Physician from UNITED STATES on May 21, 2007. Male patient, weighting 298.0 lb, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site discharge, lipodystrophy acquired, . FUZEON dosage: 90 MG BID SQ. Patient recovered.
Kenalog Side Effects Report #5272535-3
Consumer or non-health professional from UNITED STATES reported KENALOG problem on Oct 30, 2006. Female patient, 51 years of age, weighting 130.1 lb, was diagnosed with rash and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site erythema, . KENALOG dosage: unknown. During the same period patient was treated with SECTRAL. Patient recovered.
Betaseron Side Effects Report #5520097-5
BETASERON problem was reported by a Consumer or non-health professional from GERMANY on Nov 07, 2007. Female patient, 38 years of age, weighting 370.4 lb, was diagnosed with progressive multiple sclerosis, contraception and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: application site fissure, injection site atrophy, . BETASERON dosage: unknown. During the same period patient was treated with HORMONES AND RELATED AGENTS, IBUPROFEN. Patient recovered.
Betaseron Side Effects Report #5523851-9
Physician from UNITED STATES reported BETASERON problem on Nov 16, 2007. Female patient, 57 years of age, weighting 123.5 lb, was diagnosed with multiple sclerosis, insomnia and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: dry skin, injection site atrophy, injection site bruising, injection site necrosis, injection site pain, multiple sclerosis, . BETASERON dosage: unknown. During the same period patient was treated with BACLOFEN, PROZAC, TRAZODONE, TAMOXIFEN CITRATE. Patient recovered.
Betaseron Side Effects Report #5483046-4
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2007. Male patient, 48 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: cataract, injection site atrophy, injection site erythema, injection site induration, injection site pain, . BETASERON dosage: unknown. Patient recovered.
Betaseron Side Effects Report #5406384-X
Physician from UNITED STATES reported BETASERON problem on July 23, 2007. Female patient, 57 years of age, weighting 123.5 lb, was diagnosed with multiple sclerosis, insomnia and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: dry skin, injection site atrophy, injection site bruising, injection site necrosis, injection site pain, multiple sclerosis, . BETASERON dosage: unknown. During the same period patient was treated with BACLOFEN, PROZAC, TRAZODONE, TAMOXIFEN CITRATE. Patient recovered.
Medroxyprogester Side Effects Report #5730754-3
MEDROXYPROGESTERONE ACETATE problem was reported by a Health Professional from UNITED KINGDOM on Apr 25, 2008. Female patient, 32 years of age, weighting 94.80 lb, was diagnosed with contraception and was treated with MEDROXYPROGESTERONE ACETATE. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . MEDROXYPROGESTERONE ACETATE dosage: unknown. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE, HYDROXYCHLOROQUINE SULPHATE, DICLOFENAC, LEVOTHYROXINE. Patient recovered.
Sandostatin Side Effects Report #5751620-3
Consumer or non-health professional from UNITED STATES reported SANDOSTATIN LAR problem on May 20, 2008. Female patient, weighting 103.6 lb, was diagnosed with short-bowel syndrome and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: fat necrosis, injection site atrophy, . SANDOSTATIN LAR dosage: 20 MG,. During the same period patient was treated with IMODIUM, LOMOTIL. Patient recovered.
Kenalog Side Effects Report #5325079-4
KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2007. Female patient, 34 years of age, weighting 125.0 lb, was diagnosed with bursitis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, . KENALOG dosage: 40 MG 1 X. During the same period patient was treated with LIDOCAINE. Patient recovered.
Kenalog Side Effects Report #5272477-3
Consumer or non-health professional from UNITED STATES reported KENALOG problem on Apr 06, 2006. Female patient, 27 years of age, weighting 114.6 lb, was diagnosed with pharyngitis, upper respiratory tract infection and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: arthralgia, injection site atrophy, necrosis, . KENALOG dosage: unknown. Patient recovered.
Rebif Side Effects Report #5536554-1
REBIF problem was reported by a Consumer or non-health professional from FRANCE on Nov 20, 2007. Female patient, 48 years of age, weighting 134.5 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: alopecia, autoimmune thyroiditis, injection site atrophy, injection site pain, necrosis, systemic lupus erythematosus, . REBIF dosage: unknown. During the same period patient was treated with SULFARLEM, MOTILIUM, ZOLPIDEM, CLONAZEPAM, HEXAQUINE, DEXERYL, DIPROSONE, ESTREVA. Patient was hospitalized. Patient recovered.
Betaseron Side Effects Report #5460497-5
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Sept 17, 2007. Female patient, 53 years of age, was diagnosed with secondary progressive multiple sclerosis, depression, thyroid disorder and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: hemiplegia, influenza like illness, injection site atrophy, injection site discolouration, injection site necrosis, injection site reaction, lipoatrophy, muscle tightness, neuromyopathy, . BETASERON dosage: unknown. During the same period patient was treated with ZOLOFT, LEVOXYL, LORAZEPAM, IBUPROFEN. Patient was hospitalized. Patient recovered.
Betaseron Side Effects Report #5759892-6
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2008. Female patient, 39 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: abscess limb, erythema, injection site atrophy, swelling, . BETASERON dosage: unknown. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Betaseron Side Effects Report #5717470-9
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Apr 14, 2008. Female patient, 55 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypersensitivity, injection site atrophy, throat tightness, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
Kenalog Side Effects Report #5272511-0
KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2006. Female patient, 54 years of age, weighting 110.2 lb, was diagnosed with muscle twitching and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: alopecia, fat atrophy, injection site atrophy, . KENALOG dosage: unknown. During the same period patient was treated with BOTOX, TRILEPTAL, PREMARIN, LAMICTAL, LIDOCAINE. Patient recovered.